Asai A, Oshima Y, Yamamoto Y et al. (2003). “A novel telomerase template antagonist (GRN163) as a potential anticancer agent”. Cancer Res63 (14): 3931-9. PMID 12873987.
Dikmen ZG, Gellert GC, Jackson S et al. (2005). “In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor”. Cancer Res65 (17): 7866-73. PMID 16140956.
Damm K, Hemmann U, Garin-Chesa P et al. (2001). “A highly selective telomerase inhibitor limiting human cancer cell proliferation”. EMBO J.20 (24): 6958-68. PMID 11742973.
Shin-ya K, Wierzba K, Matsuo K et al. (2001). “Telomestatin, a novel telomerase inhibitor from Streptomyces anulatus”. J Am Chem Soc.123 (6): 1262-3. PMID 11456694.
Tauchi T, Shin-ya K, Sashida G et al. (2006). “Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia”. Oncogene25 (42): 5719-25. PMID 16652154.
Fossel M (1998 Jun 3). “Telomerase and the aging cell: implications for human health”. JAMA279 (21): 1732-5. PMID 9624027.
Heiss NS, Knight SW, Vulliamy TJ et al. (1998). “X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions”. Nat Genet.19 (1): 32-8. PMID 9590285.
Vulliamy T, Marrone A, Goldman F et al. (2001). “The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita”. Nature413 (6854): 432-5. PMID 11574891.
Vulliamy TJ, Walne A, Baskaradas A et al. (2005). “Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure”. Blood Cells Mol Dis.34 (3): 257-63. PMID 15885610.
pubmed.ncbi.nlm.nih.gov
Olovnikov AM (1973). “A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon”. J Theor Biol.41 (1): 181-90. PMID4754905.
Greider CW Blackburn EH (1985). “Identification of a specific telomere terminal transferase activity in Tetrahymena extracts”. Cell43 (2 Pt 1): 405–13. PMID3907856.
Szostak JW, Blackburn EH (1982). “Cloning yeast telomeres on linear plasmid vectors”. Cell29 (1): 245-55. PMID6286143.
Greider CW, Blackburn EH (1989). “A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis”. Nature337 (6205): 331-7. PMID2463488.
Gillis AJ, Schuller A, Skordalakes E (2008), “Structure of the Tribolium castaneum telomerase catalytic subunit TERT”, Nature455 (7213): 633–7, PMID18758444
Bryan TM, Englezou A, Gupta J, Bacchetti S, Reddel RR. (1995). "Telomere elongation in immortal human cells without detectable telomerase activity." EMBO J.14(17):4240-8. PMID7556065
Blasco MA. "Telomeres and human disease: aging, cancer, and beyond." Nat Rev Genet. 2005 Aug; 6(8):611-22. PMID16136653
Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA. "Telomerase reverse transcriptase delays aging in cancer-resistant mice." Cell. 2008 Nov 14;135(4):609-22 PMID19013273
de Magalhaes JP, Toussain O. "Telomeres and telomerase: a modern fountain of youth?" Rejuvenation Res. 2004 Summer; 7(2):126-33 PMID15312299
Yamaguchi H, Calado RT, Ly H et al. (2005). “Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia”. New England Journal of Medicine352 (14): 1413–24. PMID15814878.
Marrone A, Walne A, Dokal I (2005). “Dyskeratosis congenita: telomerase, telomeres and anticipation”. Curr Opin Genet Dev.15 (3): 249–57. PMID15917199.
Vulliamy TJ, Knight SW, Mason PJ, Dokal I (2001). “Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita”. Blood Cells Mol Dis.27 (2): 353–7. PMID11259155.
Armanios M, Chen JL, Chang YP et al. (2005). “Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita”. PNAS102 (44): 15960–4. doi:10.1073/pnas.0508124102. PMID16247010.
